Predictive factors for response and for resistance to tyrosine kinase inhibitor therapy in lung cancer.
Cappuzzo
Federico
F
Istituto Clinico Humanitas IRCCS, Rozzano, Italy. federico.cappuzzo@humanitas.it
D000970:Antineoplastic Agents / Q000494:pharmacology*; D014408:Biomarkers, Tumor; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005544:Forecasting; D018773:Genes, erbB-1; D018734:Genes, erbB-2; D011905:Genes, ras; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D066246:ErbB Receptors